2-cyclobutyl-2-methylpropanoic acid, 95.0%, 500mg

(R)-2-(4-Fluorophenyl)pyrrolidine, 95.0%, 100mg

Microliter syringe GASTIGHT® series 1700 Point type 2, 25 µl, 1702 RN, 1 piece

(S)-1-(3-Bromophenyl)ethanamine hydrochloride, 97%, 5g

Titanium(III,IV) oxide tablets 99.5+% dia 8-9 x 7-9 mm 50 g

2,4-Pyridinedicarboxylic Acid>98.0%(GC)25g

6-Methyl-4-(trifluoromethyl)pyridin-2-amine, 97.0%, 250mg

4-Iodobenzaldehyde, 98.0%, 100g

Thianthrene 5-Oxide>98.0%(GC)5g

5-Ethynyl-1H-pyrazole, 95+%, 1g

5-Chlorobenzofuran, 95.0%, 10g

3-Methoxymethylindole>98.0%(HPLC)(N)5g

5-Chloro-2,3-dimethoxybenzaldehyde, 95.0%, 5g